Filippo Drago Selected Research

5- (8- amino- 7- chloro- 2,3- dihydro- 1,4- benzodioxin- 5- yl)- 3- (1- (2- phenylethyl)- 4- piperidinyl)- 1,3,4- oxadiazol- 2(3H)- one

11/2006

Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Filippo Drago Research Topics

Disease

25	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 01/2008
20	Inflammation (Inflammations) 04/2021 - 04/2004
19	Schizophrenia (Dementia Praecox) 10/2022 - 04/2006
17	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 11/2007
14	Neoplasms (Cancer) 11/2021 - 07/2011
11	Glaucoma 01/2022 - 08/2002
10	Cognitive Dysfunction 10/2022 - 11/2016
8	COVID-19 01/2021 - 01/2020
7	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2021 - 11/2007
7	Mood Disorders (Mood Disorder) 04/2013 - 04/2008
6	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 01/2015
6	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2012
6	Psychotic Disorders (Schizoaffective Disorder) 12/2021 - 03/2011
5	Retinal Diseases 01/2022 - 01/2015
5	Neuroinflammatory Diseases 01/2022 - 10/2013
5	Hyperglycemia 10/2020 - 11/2014
5	Ocular Hypertension (Glaucoma, Suspect) 11/2013 - 12/2003
4	Neurobehavioral Manifestations 01/2022 - 01/2016
4	Chronic Hepatitis (Chronic Active Hepatitis) 01/2022 - 05/2014
4	Infections 01/2022 - 11/2016
4	Viremia 01/2022 - 05/2014
4	Wounds and Injuries (Trauma) 05/2021 - 12/2004
4	Ischemia 01/2021 - 09/2004
4	Memory Disorders (Memory Loss) 01/2021 - 09/2003
4	Thrombosis (Thrombus) 11/2020 - 02/2017
4	Glioblastoma (Glioblastoma Multiforme) 07/2020 - 10/2015
4	Dry Eye Syndromes (Dry Eye Syndrome) 01/2019 - 03/2014
4	Chronic Hepatitis C 08/2017 - 05/2014
4	Uveitis 01/2017 - 12/2006
4	Glioma (Gliomas) 10/2015 - 11/2008
3	Fibrosis (Cirrhosis) 01/2022 - 08/2015
3	Optic Nerve Diseases (Optic Neuropathy) 09/2021 - 11/2013
3	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 05/2021 - 01/2019
3	Parkinson Disease (Parkinson's Disease) 01/2020 - 03/2011
3	Macular Edema 10/2019 - 12/2018
3	Dementia (Dementias) 12/2017 - 11/2016
3	Down Syndrome (Down's Syndrome) 12/2017 - 11/2013
3	Mental Disorders (Mental Disorder) 01/2017 - 08/2010
3	Amnesia (Dissociative Amnesia) 11/2016 - 09/2003
3	Starvation 07/2015 - 10/2013
3	Depressive Disorder (Melancholia) 01/2014 - 06/2012
3	Type 2 Diabetes Mellitus (MODY) 02/2013 - 06/2012
2	Nervous System Diseases (Neurological Disorders) 04/2022 - 01/2018
2	Hepatitis C 01/2022 - 08/2017
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2015
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

27	Retinaldehyde (Retinal)IBA 01/2022 - 09/2004
24	Pharmaceutical PreparationsIBA 12/2021 - 09/2003
13	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2014
11	Dopamine (Intropin)FDA LinkGeneric 10/2022 - 02/2009
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2008
10	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 04/2006
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2013
9	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 12/2013
8	AntioxidantsIBA 04/2021 - 06/2012
8	Antidepressive Agents (Antidepressants)IBA 01/2021 - 08/2010
7	EndocannabinoidsIBA 10/2022 - 11/2007
7	MicroRNAs (MicroRNA)IBA 05/2021 - 01/2015
7	Peptides (Polypeptides)IBA 01/2019 - 09/2012
6	Biological ProductsIBA 11/2021 - 11/2014
6	CannabinoidsIBA 01/2021 - 09/2003
6	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 03/2018 - 09/2012
5	HomocysteineIBA 01/2022 - 01/2014
5	Neuroprotective AgentsIBA 01/2021 - 03/2011
5	Amyloid (Amyloid Fibrils)IBA 01/2021 - 02/2014
5	Streptozocin (Streptozotocin)FDA Link 02/2020 - 08/2009
4	Protein Isoforms (Isoforms)IBA 10/2022 - 07/2015
4	Methylazoxymethanol AcetateIBA 10/2022 - 01/2019
4	Dopamine D3 ReceptorsIBA 04/2022 - 09/2015
4	Purinergic P2X7 ReceptorsIBA 01/2022 - 01/2017
4	Fluoxetine (Prozac)FDA LinkGeneric 01/2021 - 07/2011
4	SteroidsIBA 12/2018 - 12/2006
4	Ribavirin (Virazole)FDA LinkGeneric 08/2017 - 05/2014
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022 - 01/2015
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2021 - 01/2010
3	CarnosineIBA 04/2021 - 01/2019
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2019
3	CannabidiolIBA 01/2021 - 01/2019
3	afliberceptIBA 12/2020 - 01/2015
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 03/2008
3	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2020 - 01/2016
3	Atropine FDA LinkGeneric 01/2019 - 01/2015
3	InterferonsIBA 08/2017 - 01/2015
3	gamma-Aminobutyric Acid (GABA)IBA 01/2017 - 05/2003
3	EndotoxinsIBA 01/2017 - 03/2008
3	Hyaluronic Acid (Hyaluronan)IBA 01/2015 - 04/2004
3	Psychotropic Drugs (Psychoactive Drugs)IBA 02/2012 - 08/2010
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2010 - 12/2003
2	Antimitotic AgentsIBA 10/2022 - 01/2019
2	AM 251 (AM251)IBA 10/2022 - 01/2019
2	DysbindinIBA 01/2022 - 01/2020
2	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2022 - 12/2020
2	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2021
2	venetoclaxIBA 12/2021 - 01/2021
2	FlavonoidsIBA 12/2021 - 07/2012

Therapy/Procedure

16	Therapeutics 01/2021 - 12/2006
5	Drug Therapy (Chemotherapy) 01/2021 - 05/2012
3	Off-Label Use 01/2021 - 01/2018
3	Topical Administration 02/2020 - 01/2015
3	Mediterranean Diet 01/2014 - 01/2013